Newsfile Corp.
Newsfile Corp
Woburn, Massachusetts--(Newsfile Corp. - December 13, 2024) - iSpecimen Inc. (NASDAQ: ISPC) ("iSpecimen" or the "Company"), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, announced today positive results attributed to its Next Day Quote Program ("NDQ"). This next-day quote service for researchers and providers is tailored to accelerate the biospecimen transaction process and delivers accurate biospecimen sample pricing within 24 hours of receiving the customer request. Next Day Quotes are possible to implement only when the Company knows the supplier's data on their specific capabilities and pricing, as well as understands the customer's requirements.
Recognizing the need for timely access to high-quality biospecimens to advance life science research, iSpecimen had introduced NDQ to offer researchers and providers with swift and accurate sample pricing. From fresh whole blood and prescreened mutation-characterized blocks to an array of clinically collected remnant, banked and prospective biospecimens, most quotes are provided within a day of receiving the inquiry.
Since introducing the program in 2023 and the recently completed build of a search tool, quotes can be created within minutes. With this capability, the Company's sales mix has increasingly shifted towards NDQ. In November 2024, 30% of all sales opportunities were Next Day Quotes. Of all quotes that were generated in November 2024, 48% were Next Day Quotes. Meanwhile, the conversion rate was high for Next Day Quotes. 60% of all purchase orders were Next Day Quotes1.
Leslie Hoyt, Senior Vice President of Operations commented, "Our customers have responded enthusiastically to iSpecimen's Next Day Quote Program. For the first six months of the program, NDQ has consistently yielded strong results, driving an estimated 60% of sales. The data continue to show that if we quote within the next business day, we greatly increase the likelihood of receiving a signed purchase order. Current and future customers respond positively because time matters."
Ms. Hoyt further commented, "We continue to enhance our internal databases and search tools to proactively harvest data, ensuring the viability of Next day Quote program while increasing the frequency with which Next Day Quotes are possible. This offering accelerates our operational timeline and the customer decision journey. Ultimately next day quotes allow researchers and providers to focus on what matters most, and iSpecimen to be a valuable service provider for all customers."
Recent ISPC News
- Form 8-K - Current report • Edgar (US Regulatory) • 03/13/2026 09:00:30 PM
- Nasdaq Microcap Soars After Unveiling AI Tool Designed to Accelerate Medical Research • AllPennyStocks.com • 03/13/2026 06:20:57 PM
- iSpecimen Launches AI Agent Revolutionizing Biospecimen Matching • GlobeNewswire Inc. • 03/12/2026 08:05:00 PM
- iSpecimen Launches AI Agent Revolutionizing Biospecimen Matching • Newsfile • 03/12/2026 08:05:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 03/03/2026 09:05:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/23/2026 09:30:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/18/2026 09:30:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/06/2026 09:05:23 PM
- iSpecimen Announces Milestone 2: System Integration and Marketplace Activation Complete • Newsfile • 02/06/2026 02:30:00 PM
- iSpecimen Achieves Rapid Procurement Milestone for Influenza Research • Newsfile • 02/06/2026 01:20:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 02/03/2026 10:15:10 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/02/2026 05:15:15 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/27/2026 09:05:25 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 01/16/2026 09:05:28 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 01/06/2026 09:30:09 PM
- E.F. Hutton & Co. Acts as Exclusive Placement Agent in iSpecimen Inc.’s ~$5.5 Million Private Placement • GlobeNewswire Inc. • 01/06/2026 03:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2026 10:15:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2026 10:06:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:00:28 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/02/2026 09:30:11 PM
- iSpecimen Inc. Announces Pricing of ~$5.5 Million Private Placement • GlobeNewswire Inc. • 12/30/2025 07:37:19 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 12/19/2025 10:00:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/01/2025 09:05:28 PM
Eco Science Solutions Integrates IDScan.net's DIVE Into Herbo Pay to Power Identity Verification, Compliance, and Fraud Prevention • ESSI • Mar 27, 2026 12:01 PM
The Crypto Company Acquires FRAME Blockchain's Technology, An "Interstate Highway" Liquidity Layer for Crypto Commerce • CRCW • Mar 26, 2026 12:28 PM
Resilient Energy Inc. Enters LOI Negtiations for Second Acquisition; First Acquisition Nears Closing • RENI • Mar 26, 2026 10:30 AM
Alliance Creative Group (ACGX) Releases 2025 Annual Financial and Disclosure Report • ACGX • Mar 26, 2026 8:30 AM
Isiah Enterprises Activates Scalable Materials Platform Targeting $900B+ Global Market Opportunity; Initiates Strategic Partner Alignment Phase • OWPC • Mar 25, 2026 9:07 AM
ECGI Signs Definitive $25 Million Agreement to Acquire RezyFi • ECGI • Mar 24, 2026 8:30 AM
